Tuberculosis of bladder
ICD-10 A18.12 is a billable code used to indicate a diagnosis of tuberculosis of bladder.
Tuberculosis of the bladder is a rare form of extrapulmonary tuberculosis that occurs when Mycobacterium tuberculosis infects the bladder. This condition can arise from hematogenous spread from a primary pulmonary infection or from direct extension from adjacent structures. Patients may present with symptoms such as dysuria, hematuria, increased urinary frequency, and pelvic pain. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and laboratory tests, including urine cultures for Mycobacterium tuberculosis, which can be challenging due to the low yield of these tests. Cystoscopy may also be performed to visualize the bladder and obtain biopsy samples. Treatment usually involves a multi-drug regimen similar to that used for pulmonary tuberculosis, including isoniazid, rifampin, ethambutol, and pyrazinamide, and may require prolonged therapy. Monitoring for drug resistance is crucial, as resistance can complicate treatment and prolong recovery. Public health implications are significant, as tuberculosis is a communicable disease, necessitating contact tracing and isolation procedures for active cases to prevent transmission.
Detailed documentation of symptoms, diagnostic tests, and treatment plans is essential.
Patients presenting with hematuria and dysuria, particularly in those with a history of tuberculosis.
Urologists should be aware of the potential for co-existing conditions and the need for comprehensive management.
Thorough documentation of the patient's history, including previous tuberculosis infections and treatment responses.
Patients with a known history of tuberculosis presenting with urinary symptoms.
Infectious disease specialists must monitor for drug resistance and ensure appropriate public health reporting.
Used to visualize the bladder and obtain biopsy samples in suspected cases of bladder tuberculosis.
Document indication for cystoscopy, findings, and any biopsies taken.
Urologists should ensure thorough documentation of findings and follow-up plans.
Common symptoms include dysuria, hematuria, increased urinary frequency, and pelvic pain. Patients may also experience systemic symptoms like fever and weight loss.
Diagnosis typically involves urine cultures for Mycobacterium tuberculosis, imaging studies, and cystoscopy with biopsy when necessary.
Treatment usually involves a multi-drug regimen similar to that for pulmonary tuberculosis, including isoniazid, rifampin, ethambutol, and pyrazinamide, often for an extended duration.
As a communicable disease, bladder tuberculosis requires contact tracing and isolation procedures for active cases to prevent transmission.
